NCT01665144 Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) Status COMPLETED Phase PHASE3
NCT01663233 Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine Status COMPLETED Phase PHASE3
NCT01661283 SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors Status COMPLETED Phase PHASE2
NCT01660295 Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects Status COMPLETED Phase PHASE1/PHASE2
NCT01658436 BEZ235 Phase II Trial in Patients With Advanced Pancreatic Neuroendocrine Tumors (pNET) After Failure of mTOR Inhibitor Therapy. Status COMPLETED Phase PHASE2
NCT01652547 A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma Status COMPLETED Phase PHASE1
NCT01651039 Phase II, Single-Center, Oral Panobinostat in Combination With Lenalidomide and Dexamethasone in Multiple Myeloma (MM) Status COMPLETED Phase PHASE2
NCT01649778 Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma Status COMPLETED Phase N/A
NCT01649466 Safety and Efficacy of Vildagliptin Versus NPH Insulin add-on to Glimepiride in Type 2 Diabetes Mellitus Patients. Status COMPLETED Phase PHASE4
NCT01649427 Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients Status COMPLETED Phase PHASE4
NCT01649375 16 Week Efficacy and 5 Year Long Term Efficacy, Safety and Tolerability of Secukinumab in Patients With Active Ankylosing Spondylitis Status COMPLETED Phase PHASE3
NCT01649050 Efficacy of 5 Weeks of Treatment With BGG492 in Patients With Spasticity Due to Multiple Sclerosis Status WITHDRAWN Phase PHASE2
NCT01647789 A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancer Status TERMINATED Phase PHASE1
NCT01646684 Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Pasireotide LAR in Patients With Castration Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT01646671 Safety and Tolerability and Efficacy of LCZ696 in Japanese Severe Hypertensive Patients Status COMPLETED Phase PHASE3
NCT01646125 An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations Status TERMINATED Phase PHASE2
NCT01643850 MCS110 in Patients With Pigmented Villonodular Synovitis (PVNS) Status COMPLETED Phase PHASE2
NCT01642732 Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer Status TERMINATED Phase PHASE1
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) Status COMPLETED Phase PHASE2
NCT01640964 An Exploratory Haemodynamic Study in Patients With Compensated Cirrhosis and Portal Hypertension Status COMPLETED Phase PHASE2